OUTREACH: PRELIMINARY SAFETY & EFFICACY RESULTS FROM A PHASE 2 STUDY OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN THE NONUNIVERSITY SETTING.

Autor:	Godwin, J. E., Mattar, B., Maris, M., Bachier, C., Stevens, D. A., Hoda, D., Varela, J. C., Cherry, M., Fanning, S., Essell, J., Yimer, H., Courtright, J., Sharman, J., Trede, N. S., Youssef, M., Lymp, J., Shaughnessy, P.
Zdroj:	Hematological Oncology; Jun2021 Supplement S2, Vol. 39, p1-3, 3p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text